RASD Family Member 2 (RASD2; Rhes; TEM2); Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
doi 10.1038/scibx.2012.52
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
2010English

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1); Transforming Growth Factor-Β1 (TGFB1; TGFβ1)

Science-Business eXchange
2010English

Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases

Biomedical Journal
Medicine
2013English

Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids

European Oncology and Haematology
OncologyHematology
2015English

Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2017English

Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2009English

Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation

Journal of Neuroscience
Neuroscience
2009English

Mammalian Target of Rapamycin (mTOR) Complex 2 Regulates Filamin A-Dependent Focal Adhesion Dynamics and Cell Migration

Genes to Cells
MedicineGeneticsCell Biology
2016English

Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy